Molina Healthcare (MOH) Reports Q2: Everything You Need To Know Ahead Of Earnings
Molina Healthcare beat analysts' revenue expectations by 2.6% last quarter, reporting revenues of $11.15 billion, up 12.2% year on year. It was a satisfactory quarter for the company, with a decent beat of analysts' EPS estimates but customer base in line with analysts' estimates. It added 217,000 customers to reach a total of 5.75 million.
Is Molina Healthcare a buy or sell going into earnings? Read our full analysis here, it's free.
This quarter, analysts are expecting Molina Healthcare's revenue to grow 10.8% year on year to $10.95 billion, slowing from the 18.7% increase it recorded in the same quarter last year.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Molina Healthcare has a history of exceeding Wall Street's expectations, beating revenue estimates every single time over the past two years by 3.2% on average.
Looking at Molina Healthcare's peers in the healthcare providers & services segment, only Elevance Health has reported results so far. It beat analysts' revenue estimates by 3%, delivering year-on-year sales growth of 13.4%. The stock was down 19.7% on the results.
Read our full analysis of Elevance Health's earnings results here.
Debates over possible tariffs and corporate tax adjustments have raised questions about economic stability in 2025. While some of the healthcare providers & services stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 2.1% on average over the last month. Molina Healthcare is down 39.5% during the same time.
Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
ChargePoint reverse stock split: EV charging company adjusts share price amid NYSE delisting risk
The stock price for the EV charging company ChargePoint Holdings (NYSE: CHPT) went up dramatically this morning—but for investors, that might not be good news. 5 habits that are making you a worse leader Zillow updates home price forecast for over 400 housing markets: See the map Figma's IPO date is close. The stock could trade even higher after the design startup's latest move ChargePoint just implemented a measure called a 'reverse stock split,' a move intended to artificially increase the share price of a company without actually boosting its overall value. Typically, a reverse stock split is used as an effort to prevent a company from being delisted from a stock exchange, and it often signals that said company is struggling financially. Investors are already demonstrating their wariness: As of this writing, ChargePoint stock is down more than 14% since the market opened this morning. Here's what to know about the company's reverse stock split. What is ChargePoint? ChargePoint Holdings is one of the largest EV charging networks in the world. The company operates more than a million chargers in the U.S. and Europe, many of which are free to use and easy to find via the company's app. In recent years, it's signed partnerships with Starbucks and Airbnb and helped to electrify an entire village in Senegal. Despite these milestones, ChargePoint has been navigating a rocky financial period. It reported a net loss of $282.9 million in the fiscal year ending in January, and, on June 5, the company shared that its first-quarter 2026 revenue was down 9% compared with the previous year. What is a reverse stock split? A reverse stock split happens when a company boosts the price tag of its stock by combining many shares into one. In the case of ChargePoint, the reverse split took place at a ratio of 1 for 20, meaning that the value of one share today is equal to 20 shares last week. A reverse stock split doesn't mean that the company's overall value has increased—it just means that there are now far fewer shares available, each at a higher cost. After the reverse stock split, ChargePoint investors will still own the same total value in the company, consolidated into fewer shares. The reverse split was approved by ChargePoint's shareholders on July 8. What's the point of a reverse stock split? Companies use a reverse stock split when, for a number of reasons, they need to artificially increase the price of their shares. According to a press release, ChargePoint took this measure to 'comply with the minimum trading price criteria for continued listing on the New York Stock Exchange (NYSE).' On the NYSE, listed companies need to maintain an average closing price of at least $1 per share over 30 consecutive trading days in order to meet the exchange's trading price criteria. In July, ChargePoint consistently traded below that $1 threshold—meaning that, without a reverse stock split, it might have been at risk of delisting. What does this mean for investors? ChargePoint's decision, paired with its recently rough financials, is likely to be a red flag for investors. The stock's current plummet shows that lack of confidence playing out in real time, demonstrating that the company is in a rough spot and is taking extreme measures to prevent delisting. In the past several years, other companies including WeWork, Virgin Galactic Holdings, and Nikola have used a similar strategy to continue trading. This post originally appeared at to get the Fast Company newsletter: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
37 minutes ago
- Business Wire
Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case
BOSTON--(BUSINESS WIRE)--A Boston jury has sided with Paul and Kathryn Lovell in a lawsuit against cosmetic behemoth Johnson & Johnson (NYSE:JNJ) that asserted Mr. Lovell's mesothelioma was directly caused by the company's iconic, asbestos-laced baby powder. The jury awarded $42,609,300, making it what lawyers believe to be the largest mesothelioma verdict in Massachusetts history. For years, Johnson & Johnson ignored its own internal warnings and scientific evidence about the presence of asbestos in its talc. The jury has sent a strong message: Corporate misconduct will not be tolerated.' Share During the two-week trial, jurors heard compelling arguments from Dean Omar Branham Shirley attorneys Aaron Chapman and Danny Kraft, who detailed how Johnson & Johnson and its affiliated entities knowingly concealed for decades the health risks associated with their talc products. The attorneys presented internal documents showing the company's awareness of asbestos contamination, its failure to adopt safer alternatives and systematic manipulation of scientific testing methods. The jury agreed that the company not only failed to warn consumers, but also actively misled the public and regulators by suppressing test results and spreading false assurances about product safety. "This verdict is not just about Paul Lovell. It's about every consumer who was told these products were safe,' said Mr. Chapman. 'For years, Johnson & Johnson ignored its own internal warnings and scientific evidence about the presence of asbestos in its talc. The jury has sent a strong message: Corporate misconduct will not be tolerated.' Mr. Lovell, 69, and his wife have been married for 45 years. A father of four, he used Johnson's Baby Powder on himself and his children, trusting it was safe. They have lived in the same home in Melrose, Massachusetts, for decades. 'Paul never worked in a factory, never used joint compound, and never had any occupational exposure to asbestos. Instead, like untold millions of Americans, he was a lifelong user of J&J's Baby Powder,' said Mr. Kraft. 'He trusted the product on himself and on his children.' The jury found the company's actions amounted to negligence and breach of warranty. The Lovell family was also represented by Leslie-Anne Taylor of Thornton Law Firm LLP. The case is Paul Lovell and Kathryn Lovell v. Johnson & Johnson, Civil Action No. 21-2086, filed in Middlesex County Superior Court in Massachusetts. Dean Omar Branham Shirley, LLP, is a nationally recognized trial firm that handles cases across the country for individuals who have suffered catastrophic injuries or have died as a result of irresponsible conduct of others. For more information, please visit
Hamilton Spectator
38 minutes ago
- Hamilton Spectator
TransAlta Declares Dividends
CALGARY, Alberta, July 29, 2025 (GLOBE NEWSWIRE) — The Board of Directors of TransAlta Corporation (TSX: TA) (NYSE: TAC) declared a quarterly dividend of $0.065 per common share payable on Oct. 1, 2025, to shareholders of record at the close of business on Sept. 1, 2025. The Board of Directors also declared the following quarterly dividend on its Cumulative Redeemable Rate Reset First Preferred Shares for the period starting from and including June 30, 2025, up to but excluding Sept. 30, 2025: * Please note the quarterly floating rate on the Series B and Series D Preferred Shares will be reset every quarter. All currency is expressed in Canadian dollars. When the dividend payment date falls on a weekend or holiday the payment is made the following business day. About TransAlta Corporation: TransAlta owns, operates and develops a diverse fleet of electrical power generation assets in Canada, the United States and Australia with a focus on long-term shareholder value. TransAlta provides municipalities, medium and large industries, businesses and utility customers with affordable, energy efficient and reliable power. Today, TransAlta is one of Canada's largest producers of wind power and Alberta's largest producer of thermal generation and hydro-electric power. For over 114 years, TransAlta has been a responsible operator and a proud member of the communities where we operate and where our employees work and live. TransAlta aligns its corporate goals with the UN Sustainable Development Goals and the Future-Fit Business Benchmark, which also defines sustainable goals for businesses. Our reporting on climate change management has been guided by the International Financial Reporting Standards (IFRS) S2 Climate-related Disclosures Standard and the Task Force on Climate-related Financial Disclosures (TCFD) recommendations. TransAlta has achieved a 70 per cent reduction in GHG emissions or 22.7 million tonnes CO2e since 2015 and received an upgraded MSCI ESG rating of AA. For more information about TransAlta, visit our web site at . For more information:
